I tried to send this before, but apparently no luck.  Someone had asked
about Wyeth pulling out ABM here in the states.  For those of you
interested, here's the release I received.
PHILADELPHIA, January 8, 1996 -- Wyeth-Ayerst (W-A)Laboratories, a
division of American Home Products Corporation (NYSE:AHP), announced
today that it will phase out its US infant nutritional products.  This
decision is limited to the infant formula product line in the 50 states,
Puerto Rico and the District of Columbia.  W-A will continue to market
infant formula outside the US.
The company's decision comes after an assessment of its strategic
strengths in light of American Home Products Corporation's acquisition of
American Cyanamid last year.  Although W-A has supplied infant formula in
the US for many years, in recent years there have been a number of
fundamental changes in the dynamics of the US marketplace.  These changes
have included the increasing costs of competing in the overall infant
nutritional market and the spiraling growth of the Women, Infants and
Children (WIC) Supplemental Food Program, which now accounts for more
than half of all formula consumed in the US.  As a result of these
changes and the company's limited presence in the US infant nutritionals
market, the domestic infant nutritional product line is not longer
viable.
Production of SMA, Nursoy, Bonamil and other specialized infant formulas
for the US market will be phased out during 1996.  The company's Mason,
Michigan plant will be closed.  However, the Georgia, Vermont plant will
continue to produce infant nutritionals for the international market.
Approximately 550 positions associated with the infant nutritional
product line in the US will be eliminated.  Non-union employees whose
jobs are eliminated will be offered comprehensive separation.....(the
rest of the paragraph states what the employees will receive.)
Parents should be assured that SMA, Nursoy, and Bonamil infant formulas
continue to be of the highest quality and will be available in retail
stores for several more months.  If parents, health care professionals or
retailers have any additional questions, they may call W-A at
1-800-999-9384.
W-A remains committed to the health care of all children and will
continue to offer a wide array of pediatric health care products,
including vaccines, anti-infectives and pediatric pharmaceuticals,
through its Wyeth-Lederle Vaccines and Pediatrics unit, which was
established after the acquisition of Amer. Cyanamid.
The phase out only affects US infant nutritional products.
Internationally, W-A has a strong presence in the infant formula market
and is committed to supporting infant nutritionals abroad.
(The last paragraph discusses that W-A is research-oriented and discusses
what areas of health care it provides products .)